home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops

Search

 
  IBC's ADMET Profiling in Drug Discovery and Development  
  June 06, 2003

Pharmacology and Toxicology

 
     
  IBC Life Sciences, Sheraton Commander Hotel, Cambridge, MA
July 28-29, 2003


Over the past five years, the pharmaceutical industry has begun to aggressively apply ADMET technology to increase success rates in the development of new drug entities. This course is designed to introduce pharmaceutical scientists in academia or industry to ADMET profiling in drug discovery. Over the course of two days, the basic principles and critical elements of successful ADMET programs will be taught. A final workshop discussion will focus on how these basic ADMET principles are applied towards optimizing candidate selection early in the drug development process.
 
 
Organized by: IBC Life Sciences
Invited Speakers: Course Instructors:

Micheline Piquette-Miller, Ph.D., Associate Professor, University of Toronto

Peter O'Brien, Ph.D., Professor of Toxicology, Faculty of Pharmacy and the Department of Pharmacology, Faculty of Medicine, University of Toronto

 
Deadline for Abstracts: -
 
Registration: Phone: (508) 616-5550 x1004 Fax: (508) 616-5522 Email: reg@ibcusa.com Online: www.LifeSciencesInfo.com/4053
E-mail: reg@ibcusa.com
 
  Posted by:   James G. Prudhomme  
Host: host-65-124-112-226.ibcusa.com
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.